TB Education and Training Network
TB Education and Training Network (ETN) and TB Program Evaluation Network (PEN) Conference
TB Education and Evaluation: Driving TB Elimination in the United States
Continuing Education Information
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live conference activity for a maximum of (12.75) AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides (12.4) contact hours.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer (1.4) CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to (9.5) total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are (0). CDC provider number 98614.
DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, our presenters and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Cathy M. Miller and she wishes to disclose that she will mention 3HP and “other short-course regimens”.
Planning committee discussed conflict of interest with Cathy M. Miller to ensure there is no bias.
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Cathy M. Miller’s discussion on current experience with 3HP treatment and other short-course regimens.
The Centers for Disease Control and Prevention and Southeastern National TB Center are jointly providing the CNE for this activity.
CDC did not accept commercial support for this continuing education activity.